Some metabolites are not easy to access. Even if sufficient material can be isolated from biological matrices for definitive metID,… read more →
As a leading specialist CRO for drug metabolite provision, Hypha has formed a partnership with Cypex Limited, experts in the… read more →
Our latest PolyCYPs bulletin features a case study in which one of our US pharma clients needed rapid access to… read more →
We are excited to announce the official launch of our One-Stop Metabolite Shop, which offers a complete solution for pharma… read more →
Hypha’s PolyCYPs enzymes have been routinely used by pharma and agchem companies for producing metabolites. One application involves direct comparison… read more →
Hypha are looking forward to presenting two posters at the ISSX meeting held in Portland US from 28th to 31st… read more →
Our newsletter this quarter looks at the use of microbial biotransformation to synthesize glucuronide metabolites, with a particular emphasis on… read more →
Hypha are excited to present a poster describing the application of PolyCYPs enzyme kits to create oxidised derivatives of drug… read more →
We have just published an article on “Accessing Difficult-to-Synthesise Metabolites in Drug Development Programmes” in the April 2019 edition of… read more →
A paper has just been published, with Hypha as co-authors, on an international collaboration to discover new drugs to treat… read more →